Arkolith/Insider Trading/CMMB/Form 4

Quigley Jill M.

DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Jun 20, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 16, 2023Grant(A)7K—$020K
Jun 16, 2022Grant(A)14K—$014K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-23-002235) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML